## Diagnosis: Thymoma ### Clinical Context and Associations **Key Point:** The strong association with myasthenia gravis (MG) is the most important clinical clue. Approximately 30-50% of thymoma patients have MG, and 10-15% of MG patients have thymoma. This patient's 15-year history of MG makes thymoma highly likely. ### Radiological Features of Thymoma | Feature | Thymoma | Lymphoma | Thymic Hyperplasia | Germ Cell Tumor | |---------|---------|----------|-------------------|----------------| | Age of onset | 40-60 years | Variable | Young adults | 20-40 years | | Border | Well-defined, smooth | Often infiltrative | Ill-defined | May be irregular | | Homogeneity | Mild heterogeneity common | Variable | Homogeneous | Heterogeneous with necrosis | | MG association | 30-50% | Rare | Rare | No | | Tumor markers | Negative | Negative | Negative | AFP/beta-hCG elevated | | Enhancement | Mild to moderate | Variable | Homogeneous | Heterogeneous | **High-Yield:** A well-defined anterior mediastinal mass in a patient with myasthenia gravis is thymoma until proven otherwise. ### Pathogenesis Thymomas arise from the epithelial cells of the thymus gland. The thymus is a primary lymphoid organ involved in T-cell maturation. Thymomas are the most common primary anterior mediastinal mass in adults aged 40-60 years. ### WHO Classification and Staging Thymomas are classified histologically (A, AB, B1, B2, B3) and staged clinically (Masaoka-Koga stages I-IV based on invasion). This patient's smooth border and lack of invasion suggest early-stage disease. ### Clinical Pearl Negative tumor markers (AFP, beta-hCG) effectively exclude germ cell tumors. The combination of MG association, patient age (52 years), well-defined mass, and negative markers is diagnostic of thymoma. ### Management Thymectomy is the treatment of choice for thymoma, especially in patients with MG. Chemotherapy and radiation may be used for advanced stages or incomplete resection. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.